- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
ContextVision AB (CONTX)
The ContextVision AB share price today is 3.56, view OL CONTX stock exchange data. Track the latest ContextVision AB share price with real-time updates on CONTX stock performance including market cap, day range, 52-week range and dividend yield. Access CONTX charts, earnings dates and analyst estimates to support your investment decisions.
3.56
-0.04(-1.11%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.45
3.60
52 wk Range
2.70
5.60
CONTX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.453.60
52 wk Range
2.705.60
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CONTX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Neutral
Price Target
3.30
Downside
-7.30%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Strong Buy
Analyst Ratings
0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 3.30
(-7.30% Downside)
Earnings
Latest Release
19-02-2026
EPS / Forecast
0.07 / 0.10
Revenue / Forecast
31.7M / 38M
Compare CONTX to Peers and Sector
Metrics to compare | CONTX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCONTXPeersSector | |
|---|---|---|---|---|
P/E Ratio | 338.0x | 14.4x | −0.5x | |
PEG Ratio | −3.49 | 0.09 | 0.00 | |
Price/Book | 2.9x | 1.2x | 2.6x | |
Price / LTM Sales | 2.4x | 1.9x | 3.2x | |
Upside (Analyst Target) | −7.3% | 48.9% | 47.8% | |
Fair Value Upside | Unlock | 10.0% | 5.9% | Unlock |
ContextVision AB (publ), a software company, provides image analysis and imaging for medical systems in South Korea, China, Japan, the United States, and internationally. The company offers image quality solutions for ultrasound, as well as its Rivent platform comprising Rivent, a 2D image enhancement; Rivent Plus, a premium 2D image enhancement product; Rivent 3D, a solution for improving image quality of 3D ultrasound; and Rivent Mobile, a 2D image enhancement for handheld devices for diagnostics in various fields, including radiology, cardiology, women’s health, veterinary medicine, and point of-care applications. It also provides Altumira platform, which features scatter correction and improves radiography by enabling radiation dose reduction while enhancing image quality, such as Altumira for static applications; and Altumira Plus for dynamic applications. In addition, the company offers image quality solutions for MRI including GOPView MRI2Plus for the requirements of each application, sequence type, and protocol; and implementation projects, software updates, and upgrades and product support services. It has a strategic clinical development partnership with the University of Washington School of Medicine for collecting medical imaging data to identify a multiparametric biomarker for the screening and staging of the liver disease MASLD; and research partnership with AMRA Medical to develop AI-powered, organ-specific imaging solutions that enable MASLD screening and physiological quantification. It also has a strategic research and development collaboration with BeamWorks Inc. for the development of AI-powered quantitative ultrasound imaging solutions. ContextVision AB (publ) was incorporated in 1989 and is headquartered in Stockholm, Sweden.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the ContextVision AB (CONTX) Share Price Today?
The ContextVision AB share price today is 3.56.
What is the current ContextVision AB (CONTX) share price and day range?
As of 06-05-2026, the ContextVision AB share price is 3.56, with a previous close of 3.56. The share price has ranged from 3.45 to 3.60 today, while the 52-week range spans from 2.70 to 5.60.
What Is the ContextVision AB Market Cap?
As of today, ContextVision AB market cap is 265.70M.
What Is the ContextVision AB (CONTX) Share Price Target?
The average 12-month share price target for ContextVision AB is 3.30, with a high estimate of 3.3 and a low estimate of 3.3. 0 analysts recommend buying, while 0 suggest selling, with an overall rating of Neutral and -7.30% Downside potential.
What Is ContextVision AB's Earnings Per Share (TTM)?
The ContextVision AB EPS (TTM) is 0.01.
When Is the Next ContextVision AB Earnings Date?
ContextVision AB will release its next earnings report on 08-05-2026.
From a Technical Analysis Perspective, Is CONTX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
What Stock Exchange Does ContextVision AB Trade On?
ContextVision AB is listed and trades on the Oslo Stock Exchange.
What Is the Stock Symbol for ContextVision AB?
The stock symbol for ContextVision AB is "CONTX."
How Many Times Has ContextVision AB Stock Split?
ContextVision AB has split 1 times.
How Many Employees Does ContextVision AB Have?
ContextVision AB has 43 employees.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.